In addition, EGFR overexpression is involved in CDDP resistance in esophageal adenocarcinoma [12], and combined treatments with CDDP and EGFR inhibitors show enhanced susceptibility to CDDP-mediated apoptosis in OSCC cells [13]. The gene discussed is EGFR; the disease is esophageal adenocarcinoma.